Standout Papers
- [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer (2022)
- Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy (2019)
- Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer (2014)
Immediate Impact
1 from Science/Nature 69 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
2024 Standout
Works of Ute Hennrich being referenced
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
2021
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ute Hennrich | 687 | 457 | 416 | 12 | 1.0k | |
| Ingo Klette | 1030 | 802 | 437 | 15 | 1.3k | |
| Sally W. Schwarz | 933 | 327 | 355 | 42 | 1.2k | |
| Jakub Šimeček | 1084 | 640 | 514 | 28 | 1.4k | |
| S. M. Larson | 902 | 302 | 397 | 23 | 1.3k | |
| Annemarie Eek | 682 | 237 | 496 | 28 | 1.2k | |
| Eleni Gourni | 596 | 296 | 644 | 41 | 1.1k | |
| Irina Velikyan | 709 | 221 | 404 | 28 | 943 | |
| Mickaël Bourgeois | 622 | 196 | 306 | 45 | 951 | |
| Markus Jahn | 412 | 166 | 176 | 15 | 1.0k | |
| Jessie R. Nedrow | 774 | 399 | 479 | 33 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...